SIMPLE SPECTROPHOTOMETRIC METHODS FOR ESTIMATION OF DRUGS AND PHARMACEUTICALS USING NBS-METHYL ORANGE DYE COUPLE

被引:1
作者
Reddy, B. Vishnuvardhan [1 ]
Mamidi, Gopi [1 ]
Venkateshwarlu, G. [1 ]
机构
[1] Osmania Univ, Univ Coll Sci, Dept Chem, Hyderabad 500007, Telangana, India
关键词
Argatrobane monohydrate; Bortezomib; Chloroquine phosphate; Granisetron HCl; Ibandronate sodium; Estimation; NBS; Methyl orange; IBANDRONATE; CHLOROQUINE; ARGATROBAN; PYRIMETHAMINE; BORTEZOMIB; HPLC;
D O I
10.13040/IJPSR.0975-8232.10(9).4215-22
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Simple. sensitive. cost-effective and selective methods are designed and developed for the oxidative indirect spectrophotometric determination of drugs and pharmaceuticals, viz.. Argatrobane Monohydrate (ARG), Bortezomib (BOR). Chloroquine Phospate (CHP). Granisetron HCl (GRA), Ibandronate Sodium (IBA) based on their reactivity towards n-bromo succinamide (NBS in excess). The method is based on the oxidation of drugs by n-bromo succinamide (excess) and estimating the amount of un-reacted NBS by Methyl Orange dye at lambda(max) 508 nm. The calibration curves obeyed Beer's law over the concentration range of 10-70 mu g mL(-1) (ARG). 8-56 mu g mL(-1) (BOR). 6-42 mu g mL(-1) (CHP). 4-28 mu g mL(-1) (GRA) & 5-35 mu g mL(-1) (IBA). This method has been applied for the determination of drugs in their pure form as well as in tablet formulations. Statistical analysis of the results using Student's t-test for accuracy and F-test for precision revealed no significant difference between the proposed methods and the literature method at the 95% confidence level with respect to accuracy and precision. The method has been validated in terms of guidelines of the International Council of Harmonization.
引用
收藏
页码:4215 / 4222
页数:8
相关论文
共 37 条
[1]  
Aggarwal Geeta, 2017, Pharmaceutical Nanotechnology, V5, P317, DOI 10.2174/2211738505666170915151118
[2]   Simultaneous monitoring of argatroban and its major metabolite using an HPLC method: Potential clinical applications [J].
Ahmad, S ;
Ahsan, A ;
George, M ;
Iqbal, O ;
Jeske, WP ;
McKenna, R ;
Lewis, BE ;
Walenga, JM ;
Fareed, J .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1999, 5 (04) :252-258
[3]  
[Anonymous], 2005, TEXT METH INT C HARM, P1
[4]  
Burgess E, 2002, AM J HYPERTENS, V15, P57
[5]   Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease [J].
Coleman, RE ;
Purohit, OP ;
Black, C ;
Vinholes, JJF ;
Schlosser, K ;
Huss, H ;
Quinn, KJ ;
Kanis, J .
ANNALS OF ONCOLOGY, 1999, 10 (03) :311-316
[6]  
Da-qing G, 2009, CENTRAL S PHARM, V3, P134
[7]   Determination of anti-malaria agent chloroquine using single drop liquid-liquid-liquid microextraction [J].
Daneshfar, Ali ;
Khezeli, Tahere ;
Manafi, Mohamad H. .
JOURNAL OF SEPARATION SCIENCE, 2009, 32 (04) :511-516
[8]   Argatroban: A direct thrombin inhibitor with reliable and predictable anticoagulant actions [J].
Escolar, Gines ;
Bozzo, Jordi ;
Maragall, Santiago .
DRUGS OF TODAY, 2006, 42 (04) :223-236
[9]  
Gawad JB, 2012, INT J INNOVATIVE PHA, V3, P220
[10]  
Gennaro, 2000, SCI PRACTICE PHARM, P1547